Murine models of pulmonary tumors have long provided investigators a reliable and reproducible method of testing the therapeutic efficacy of adoptive immunotherapy. Adoptive immunotherapy involves the generation of tumor-specific immune cells which, following activation and culture in vitro, can mediate regression of established tumors following transfer into a tumor-bearing host.
